Completed PHASE3 INTERVENTIONAL 2-arm NCT02168426

Randomized Control Trial on Seprafilm and Guardix in Preventing Ileus

Sponsor: Gachon University Gil Medical Center

Conditions Patient Under Going Colorectal and Stomach Cancer Surgery

Updated 6 times since 2017 Last updated: Aug 28, 2015 Started: Aug 31, 2013 Primary completion: Dec 31, 2014 Completion: Feb 28, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02168426, this PHASE3 trial focuses on Patient Under Going Colorectal and Stomach Cancer Surgery and remains completed. Sponsored by Gachon University Gil Medical Center, it has been updated 6 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gachon University Gil Medical Center

Data source: Gachon University Gil Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Incheon, South Korea